| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6636b59c3149a23a6ae7feaa3984d05f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b41481e017d0dc3ec89312039d814187
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b3c2e77f8dfda692ca527454d23ecc03
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ec522b2d085985f8d1741840ec92bf91
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_74c23ce3b30df24d05a1c21106e23c49
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bc2fb9d65d9af8d2133982ff7a700af2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_be318f6606e9ba6f611b0d7502f191d3 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4741
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4745
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4741
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4745 |
| filingDate |
2009-08-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bc21f1307ba5119c7b8309cd446df5fd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9ed1df09de672c088696b8addd190aa1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2ad01bd1918ff82246c27329e0e4e1ed
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a00de8a2e033e272b07c8df6967215f8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_24f25c646c87a9cd01e48ff1c35eb8a0 |
| publicationDate |
2010-07-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2010022238-A9 |
| titleOfInvention |
Anti-flavivirus therapeutic |
| abstract |
The present invention relates to anti-flavivirus compounds, including lycorine and derivatives thereof, and their use in treating a subject infected by a flavivirus. The present invention also relates to the use of the anti-flavivirus compounds for the prophylaxis of flavivirus infection. The present invention further relates to a method of suppressing viral RNA synthesis of a flavivirus. Also described is a method of preparing an anti-flavivirus compound for use in the treatment or prophylaxis of flavivirus infection. |
| priorityDate |
2008-08-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |